Skip to main content
logo
GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)
India flag India · Delayed Price · Currency is INR
2,438.90
+22.20 (0.92%)
May 15, 2026, 3:29 PM IST

NSE:GLAXO Revenue

In the fiscal year ending March 31, 2026, GlaxoSmithKline Pharmaceuticals had annual revenue of 39.67B INR with 5.81% growth. GlaxoSmithKline Pharmaceuticals had revenue of 10.31B in the quarter ending March 31, 2026, with 5.84% growth.

Revenue
39.67B
Revenue Growth
+5.81%
P/S Ratio
10.42
Revenue / Employee
12.74M
Employees
3,113
Market Cap
413.31B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202639.67B2.18B5.81%
Mar 31, 202537.49B2.96B8.56%
Mar 31, 202434.54B2.02B6.21%
Mar 31, 202332.52B-263.06M-0.80%
Mar 31, 202232.78B3.52B12.05%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sun Pharmaceutical Industries568.09B
Cipla279.67B
Apollo Hospitals Enterprise242.15B
Divi's Laboratories103.14B
Ipca Laboratories95.06B
Emcure Pharmaceuticals92.04B
Narayana Hrudayalaya67.78B
Ajanta Pharma54.53B
Revenue Rankings

GlaxoSmithKline Pharmaceuticals News

More News